Table 2.
Prevalence of HPV Vaccine Awareness and Initiation by Sex of Sexual Partners
| Variable | Total | Ever heard of HPV vaccine (N=3,253) | Ever received HPV vaccinea (N=2,698) | ||||
|---|---|---|---|---|---|---|---|
| n | Prevalence estimate (%) | 95% CI | n | Prevalence estimate (%) | 95% CI | ||
| Total | 3,253 | 2,698 | 84.4 | 81.5, 86.9 | 790 | 28.5 | 25.4, 31.8 |
| Sex of lifetime sexual partners | |||||||
| Only male | 1,889 | 1,569 | 85.3 | 82.5, 87.8 | 458 | 28.5 | 24.5, 32.9 |
| Both male and female | 493 | 440 | 88.9 | 84.1, 92.3 | 108 | 26.8 | 21.0, 33.6 |
| Only female | 46 | 37 | 84.8 | 64.5, 94.5 | 9 | 27.7 | 11.1, 54.1 |
| None | 798 | 637 | 81.1 | 76.8, 84.7 | 212 | 30.0 | 25.4, 35.0 |
| Sex of past-year sexual partners | |||||||
| Only male | 1,973 | 1,663 | 85.9 | 83.2, 88.3 | 471 | 28.3 | 24.4, 32.5 |
| Both male and female | 192 | 172 | 92.8 | 87.5, 95.9 | 43 | 27.1 | 18.0, 38.5 |
| Only female | 60 | 47 | 79.1 | 58.7, 91.0 | 6 | 6.2 | 1.8, 19.3 |
| None | 989 | 794 | 81.7 | 77.7, 85.1 | 266 | 30.6 | 26.2, 35.5 |
Notes: HPV, human papillomavirus.
Analyses were restricted to women who participated in Years 2-4 of the survey. Sample sizes (N, n) refer to observed counts. All prevalence estimates (%) and 95% CI account for the complex survey design.
a
Only applies to those who reported having ever heard of the HPV vaccine.